In the view of yet to beginning precautionary Wuhan virus vaccine drive, the Serum Institute of India (SII) manufactured Covisheild reduced its price for private hospitals. Initially, the Covishield dose…
Recently, India’s Central Drug Regulator, the Drugs Controller General of India (DCGI,) granted emergency use authorisation (EUA) to the Serum Institute of India manufactured Covovax, the Wuhan virus vaccine for…
The Serum Institute of India Chief Executive Officer (CEO) Adar Poonawalla, on the 14th of December, announced to launch vaccine against the Wuhan virus for children, above3+ years old. The…
On the 26th of November, Mr. Adar Poonawalla, the Chief Executive Officer (CEO) of the Serum Institute of India (SII) announced the resumption of export Covishield. The export of Covishield,…
On the 3rd of June, the Serum Institute of India (SII) sought permission to manufacture the Russian made Sputnik V, a vaccine against the Wuhan virus. The SII submitted an…
On the 31st of May, an Uttar Pradesh resident filed a complaint against the Serum Institute of India (SII) Chief Executive Officer (CEO,) Adar Poonawala. Identified as Pratap Chandra, a…
The Serum Institute of India (SII) on the 18th of May, said it had never exported vaccines to other countries at the cost of the people of India. The statement…
On the 28th of April, the Pune based pharmaceutical company the Serum Institute of India (SII) announced the reduced prices of Covisheild, an anti Novel Coronavirus vaccine. The newly reduced…
The Indian National Congress (INC) slammed the Central Government for their recently announced vaccination policy for the third phase. On the 19th of April, the Government of India allowed vaccination…
The Serum Institute of India (SII,) on the 21st of April, announced new prices of the SII manufactured anti Novel Coronavirus vaccine, Covisheild. According to the sources, the new prices…
